Cargando…
Efficacy of Wholistic Turmeric Supplement on Adenomatous Polyps in Patients with Familial Adenomatous Polyposis—A Randomized, Double-Blinded, Placebo-Controlled Study
Several studies have demonstrated that curcumin can cause the regression of polyps in familial adenomatous polyposis (FAP), while others have shown negative results. Wholistic turmeric (WT) containing curcumin and additional bioactive compounds may contribute to this effect. We performed a double-bl...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777742/ https://www.ncbi.nlm.nih.gov/pubmed/36553450 http://dx.doi.org/10.3390/genes13122182 |
_version_ | 1784856180968914944 |
---|---|
author | Gilad, Ophir Rosner, Guy Ivancovsky-Wajcman, Dana Zur, Reut Rosin-Arbesfeld, Rina Gluck, Nathan Strul, Hana Lehavi, Dana Rolfe, Vivien Kariv, Revital |
author_facet | Gilad, Ophir Rosner, Guy Ivancovsky-Wajcman, Dana Zur, Reut Rosin-Arbesfeld, Rina Gluck, Nathan Strul, Hana Lehavi, Dana Rolfe, Vivien Kariv, Revital |
author_sort | Gilad, Ophir |
collection | PubMed |
description | Several studies have demonstrated that curcumin can cause the regression of polyps in familial adenomatous polyposis (FAP), while others have shown negative results. Wholistic turmeric (WT) containing curcumin and additional bioactive compounds may contribute to this effect. We performed a double-blinded, randomized, controlled trial to assess the efficacy of WT in FAP patients. Ten FAP patients were randomly assigned to receive either WT or placebo for 6 months. Colonoscopies were performed at baseline and after 6 months. The polyp number and size, as well as the cumulative polyp burden, were assessed. No differences were noted between the groups in terms of changes from the baseline’s polyp number, size, or burden. However, stratifying the data according to the right vs. left colon indicated a decrease in the median polyp number (from 5.5 to 1.5, p = 0.06) and polyp burden (from 24.25 mm to 11.5 mm, p = 0.028) in the left colon of the patients in the WT group. The adjusted left polyp number and burden in the WT arm were lower by 5.39 (p = 0.034) and 14.68 mm (p = 0.059), respectively. Whether WT can be used to reduce the polyp burden of patients with predominantly left-sided polyps remains to be seen; thus, further larger prospective trials are required. |
format | Online Article Text |
id | pubmed-9777742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97777422022-12-23 Efficacy of Wholistic Turmeric Supplement on Adenomatous Polyps in Patients with Familial Adenomatous Polyposis—A Randomized, Double-Blinded, Placebo-Controlled Study Gilad, Ophir Rosner, Guy Ivancovsky-Wajcman, Dana Zur, Reut Rosin-Arbesfeld, Rina Gluck, Nathan Strul, Hana Lehavi, Dana Rolfe, Vivien Kariv, Revital Genes (Basel) Article Several studies have demonstrated that curcumin can cause the regression of polyps in familial adenomatous polyposis (FAP), while others have shown negative results. Wholistic turmeric (WT) containing curcumin and additional bioactive compounds may contribute to this effect. We performed a double-blinded, randomized, controlled trial to assess the efficacy of WT in FAP patients. Ten FAP patients were randomly assigned to receive either WT or placebo for 6 months. Colonoscopies were performed at baseline and after 6 months. The polyp number and size, as well as the cumulative polyp burden, were assessed. No differences were noted between the groups in terms of changes from the baseline’s polyp number, size, or burden. However, stratifying the data according to the right vs. left colon indicated a decrease in the median polyp number (from 5.5 to 1.5, p = 0.06) and polyp burden (from 24.25 mm to 11.5 mm, p = 0.028) in the left colon of the patients in the WT group. The adjusted left polyp number and burden in the WT arm were lower by 5.39 (p = 0.034) and 14.68 mm (p = 0.059), respectively. Whether WT can be used to reduce the polyp burden of patients with predominantly left-sided polyps remains to be seen; thus, further larger prospective trials are required. MDPI 2022-11-22 /pmc/articles/PMC9777742/ /pubmed/36553450 http://dx.doi.org/10.3390/genes13122182 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gilad, Ophir Rosner, Guy Ivancovsky-Wajcman, Dana Zur, Reut Rosin-Arbesfeld, Rina Gluck, Nathan Strul, Hana Lehavi, Dana Rolfe, Vivien Kariv, Revital Efficacy of Wholistic Turmeric Supplement on Adenomatous Polyps in Patients with Familial Adenomatous Polyposis—A Randomized, Double-Blinded, Placebo-Controlled Study |
title | Efficacy of Wholistic Turmeric Supplement on Adenomatous Polyps in Patients with Familial Adenomatous Polyposis—A Randomized, Double-Blinded, Placebo-Controlled Study |
title_full | Efficacy of Wholistic Turmeric Supplement on Adenomatous Polyps in Patients with Familial Adenomatous Polyposis—A Randomized, Double-Blinded, Placebo-Controlled Study |
title_fullStr | Efficacy of Wholistic Turmeric Supplement on Adenomatous Polyps in Patients with Familial Adenomatous Polyposis—A Randomized, Double-Blinded, Placebo-Controlled Study |
title_full_unstemmed | Efficacy of Wholistic Turmeric Supplement on Adenomatous Polyps in Patients with Familial Adenomatous Polyposis—A Randomized, Double-Blinded, Placebo-Controlled Study |
title_short | Efficacy of Wholistic Turmeric Supplement on Adenomatous Polyps in Patients with Familial Adenomatous Polyposis—A Randomized, Double-Blinded, Placebo-Controlled Study |
title_sort | efficacy of wholistic turmeric supplement on adenomatous polyps in patients with familial adenomatous polyposis—a randomized, double-blinded, placebo-controlled study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777742/ https://www.ncbi.nlm.nih.gov/pubmed/36553450 http://dx.doi.org/10.3390/genes13122182 |
work_keys_str_mv | AT giladophir efficacyofwholisticturmericsupplementonadenomatouspolypsinpatientswithfamilialadenomatouspolyposisarandomizeddoubleblindedplacebocontrolledstudy AT rosnerguy efficacyofwholisticturmericsupplementonadenomatouspolypsinpatientswithfamilialadenomatouspolyposisarandomizeddoubleblindedplacebocontrolledstudy AT ivancovskywajcmandana efficacyofwholisticturmericsupplementonadenomatouspolypsinpatientswithfamilialadenomatouspolyposisarandomizeddoubleblindedplacebocontrolledstudy AT zurreut efficacyofwholisticturmericsupplementonadenomatouspolypsinpatientswithfamilialadenomatouspolyposisarandomizeddoubleblindedplacebocontrolledstudy AT rosinarbesfeldrina efficacyofwholisticturmericsupplementonadenomatouspolypsinpatientswithfamilialadenomatouspolyposisarandomizeddoubleblindedplacebocontrolledstudy AT glucknathan efficacyofwholisticturmericsupplementonadenomatouspolypsinpatientswithfamilialadenomatouspolyposisarandomizeddoubleblindedplacebocontrolledstudy AT strulhana efficacyofwholisticturmericsupplementonadenomatouspolypsinpatientswithfamilialadenomatouspolyposisarandomizeddoubleblindedplacebocontrolledstudy AT lehavidana efficacyofwholisticturmericsupplementonadenomatouspolypsinpatientswithfamilialadenomatouspolyposisarandomizeddoubleblindedplacebocontrolledstudy AT rolfevivien efficacyofwholisticturmericsupplementonadenomatouspolypsinpatientswithfamilialadenomatouspolyposisarandomizeddoubleblindedplacebocontrolledstudy AT karivrevital efficacyofwholisticturmericsupplementonadenomatouspolypsinpatientswithfamilialadenomatouspolyposisarandomizeddoubleblindedplacebocontrolledstudy |